WalterThomasJenkinsMD

PubMed

• Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients.
  Koch, C. J.,Lustig, R. A.,Yang, X. Y.,Jenkins, W. T.,Wolf, R. L.,Martinez-Lage, M.,Desai, A.,Williams, D.,Evans, S. M.> ;Transl Oncol. 2014 Dec 17
• Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells.
  Sood N, Jenkins WT, Yang X, Shah NN, Katz JS, Koch CJ, Frail PR, Therien MJ, Hammer DA, Evans SM> ;J Pharm (Cairo). 2013-01-01
• The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.
  Koch CJ, Shuman AL, Jenkins WT, Kachur AV, Karp JS, Freifelder R, Dolbier WR, Evans SM> ;Int. J. Radiat. Biol.. 2009-12-01
• Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning.
  Poptani, H., Bansal, N., Jenkins, W.T., Blessington, D., Mancuso, A., Nelson, D.S., Feldman, M., Delikatny, E.J., Chance, B., Glickson, J.D.> ;Cancer Res. 2003 Dec 15
• Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
  Ziemer LS, Evans SM, Kachur AV, Shuman AL, Cardi CA, Jenkins WT, Karp JS, Alavi A, Dolbier WR, Koch CJ> ;Eur. J. Nucl. Med. Mol. Imaging. 2003-02-01
• Effects of hyperglycemia on oxygenation, radiosensitivity and bioenergetic status of subcutaneous RIF-1 tumors.
  Nadal-Desbarats L, Poptani H, Oprysko P, Jenkins WT, Busch TM, Nelson DS, Glickson JD, Koch CJ, Evans SM> ;Int. J. Oncol.. 2002-07-01
• Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations.
  Gee MS, Saunders HM, Lee JC, Sanzo JF, Jenkins WT, Evans SM, Trinchieri G, Sehgal CM, Feldman MD, Lee WM> ;Cancer Res.. 2001-04-01
• Hypoxia in human intraperitoneal and extremity sarcomas.
  Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, Koch CJ> ;Int. J. Radiat. Oncol. Biol. Phys.. 2001-02-01
• Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
  Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ> ;Cancer Res.. 2000-04-01
• Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
  Jenkins WT, Evans SM, Koch CJ> ;Int. J. Radiat. Oncol. Biol. Phys.. 2000-03-01
• Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1.
  Evans SM, Kachur AV, Shiue CY, Hustinx R, Jenkins WT, Shive GG, Karp JS, Alavi A, Lord EM, Dolbier WR, Koch CJ> ;J. Nucl. Med.. 2000-02-01
• Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12.
  Gee MS, Koch CJ, Evans SM, Jenkins WT, Pletcher CH, Moore JS, Koblish HK, Lee J, Lord EM, Trinchieri G, Lee WM> ;Cancer Res.. 1999-10-01
• MIBG inhibits respiration: potential for radio- and hyperthermic sensitization.
  Biaglow JE, Manevich Y, Leeper D, Chance B, Dewhirst MW, Jenkins WT, Tuttle SW, Wroblewski K, Glickson JD, Stevens C, Evans SM> ;Int. J. Radiat. Oncol. Biol. Phys.. 1998-11-01
• Co-localization of hypoxia and apoptosis in irradiated and untreated HCT116 human colon carcinoma xenografts.
  Koch CJ, Chasan JE, Jenkins WT, Chan CY, Laughlin KM, Evans SM> ;Adv. Exp. Med. Biol.. 1998-01-01
• Oxygen distributions within R3230Ac tumors growing in dorsal flap window chambers in rats.
  Wilson DF, Evans SM, Jenkins WT, Vinogradov SA, Ong E, Dewhirst MW> ;Adv. Exp. Med. Biol.. 1998-01-01
• Tamoxifen induces hypoxia in MCF-7 xenografts.
  Evans SM, Koch CJ, Laughlin KM, Jenkins WT, Van Winkle T, Wilson DF> ;Cancer Res.. 1997-11-15
• Oxygen distribution in the vasculature of mouse tissue in vivo measured using a near infra red phosphor.
  Lo LW, Jenkins WT, Vinogradov SA, Evans SM, Wilson DF> ;Adv. Exp. Med. Biol.. 1997-01-01
• Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
  Evans SM, Jenkins WT, Shapiro M, Koch CJ> ;Adv. Exp. Med. Biol.. 1997-01-01
• Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.
  Laughlin KM, Evans SM, Jenkins WT, Tracy M, Chan CY, Lord EM, Koch CJ> ;J. Pharmacol. Exp. Ther.. 1996-05-01
• Noninvasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors.
  Vinogradov SA, Lo LW, Jenkins WT, Evans SM, Koch C, Wilson DF> ;Biophys. J.. 1996-04-01
• 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
  Evans SM, Jenkins WT, Joiner B, Lord EM, Koch CJ> ;Cancer Res.. 1996-01-15
• Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
  Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch CJ> ;Br. J. Cancer. 1995-10-01
• The induction of DNA-protein crosslinks in hypoxic cells and their possible contribution to cell lethality.
  Meyn RE, vanAnkeren SC, Jenkins WT> ;Radiat. Res.. 1987-03-01
• Radiation damage to DNA in various animal tissues: a comparison of yields and repair in vivo and in vitro.
  Meyn RE, Jenkins WT, Murray D> ;Basic Life Sci.. 1986-01-01
• Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
  Murray D, Jenkins WT, Meyn RE> ;Cancer Res.. 1985-12-01
• Join now to see all